Study researchers surveyed community-based physicians in order to understand what drives treatment decision-making in mCRC in the third-line setting.

In this analysis, researchers aimed to determine whether intermediate dose escalation is beneficial in resectable, stage III NSCLC patients who receive definitive concurrent chemoradiation followed by ...

On the same day the lawsuit was filed, the administration also announced plans to cut another $183 million in unused public health funds. That round of cuts includes block grants from the U.S. Centers ...

The NDA is supported by data from the EXCALIBER-RRMM trial, which evaluated the safety and efficacy of iberdomide, an investigational cereblon E3 ligase modulator.

The NDA is supported by data from part A of the phase 2 PROSPECT trial, which evaluated tirabrutinib in 48 adult patients with R/R PCNSL.

In this study, researchers reported on 10-year follow-up of a phase 3 trial comparing surgery to chemoradiation boost in resectable, advanced NSCLC.

Investigators assessed whether women preferred at-home self-sampling or clinical testing for cervical cancer screening.

Middle-aged Americans with Medicaid now worry about losing their coverage as new work rule changes are signed into law.

International variation in overall survival linked to differences in childhood tumor stage distribution for some cancer types and regions ...

(HealthDay News) — The increased number of state-level abortion restrictions in the United States from 2005 to 2023 was associated with an increase in maternal deaths, according to a study presented ...

Semi-structured interviews with healthcare providers and female cancer survivors explored the perceived benefits of improved nutrition counseling for these survivors.

In this study, researchers aimed to examine trends in nonsurgical management and other treatment modalities in low-risk, HR-positive DCIS.